CINECA IRIS Institutional Research Information System

SARTINI, STEFANIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.505
EU - Europa 1.772
AS - Asia 1.453
SA - Sud America 182
AF - Africa 87
OC - Oceania 5
Continente sconosciuto - Info sul continente non disponibili 1
Totale 7.005
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.410
IT - Italia 698
SG - Singapore 505
CN - Cina 410
DE - Germania 243
SE - Svezia 239
HK - Hong Kong 171
VN - Vietnam 157
BR - Brasile 151
AT - Austria 122
BG - Bulgaria 97
FR - Francia 85
GB - Regno Unito 82
FI - Finlandia 73
CA - Canada 67
RU - Federazione Russa 45
TR - Turchia 45
IN - India 42
CI - Costa d'Avorio 35
JP - Giappone 29
MX - Messico 18
NL - Olanda 18
BD - Bangladesh 17
UA - Ucraina 17
NG - Nigeria 14
BE - Belgio 13
IQ - Iraq 12
ZA - Sudafrica 11
AR - Argentina 10
ES - Italia 9
PL - Polonia 9
SA - Arabia Saudita 8
UZ - Uzbekistan 8
CO - Colombia 7
DK - Danimarca 6
ID - Indonesia 6
MA - Marocco 6
PK - Pakistan 6
SN - Senegal 6
EC - Ecuador 5
KR - Corea 5
VE - Venezuela 5
AU - Australia 4
CH - Svizzera 4
EG - Egitto 4
JO - Giordania 4
AZ - Azerbaigian 3
CZ - Repubblica Ceca 3
LB - Libano 3
LT - Lituania 3
NP - Nepal 3
TN - Tunisia 3
AL - Albania 2
CL - Cile 2
HN - Honduras 2
IL - Israele 2
IR - Iran 2
JM - Giamaica 2
KE - Kenya 2
KH - Cambogia 2
KZ - Kazakistan 2
MY - Malesia 2
PE - Perù 2
PH - Filippine 2
PS - Palestinian Territory 2
RS - Serbia 2
SY - Repubblica araba siriana 2
AG - Antigua e Barbuda 1
AO - Angola 1
BB - Barbados 1
BJ - Benin 1
CG - Congo 1
CR - Costa Rica 1
DZ - Algeria 1
ET - Etiopia 1
EU - Europa 1
GD - Grenada 1
HU - Ungheria 1
LA - Repubblica Popolare Democratica del Laos 1
LK - Sri Lanka 1
NZ - Nuova Zelanda 1
PA - Panama 1
PT - Portogallo 1
SV - El Salvador 1
TG - Togo 1
YE - Yemen 1
Totale 7.005
Salva come PNG Salva come JPEG
Città #
Ashburn 348
Woodbridge 307
Singapore 272
Fairfield 271
Ann Arbor 265
Serra 253
Chandler 185
Dallas 179
Houston 172
Hong Kong 171
San Jose 156
Santa Clara 155
Seattle 131
Beijing 114
Wilmington 99
Sofia 97
Vienna 92
Cambridge 91
Shanghai 90
New York 80
Council Bluffs 55
Los Angeles 52
Princeton 48
Boardman 47
Dong Ket 44
Milan 44
Ottawa 42
Helsinki 39
Lawrence 36
Abidjan 35
Frankfurt am Main 35
Rho 35
Medford 34
Lauterbourg 33
Pisa 31
Ho Chi Minh City 27
Florence 24
Tokyo 24
Nanjing 23
Izmir 22
London 22
Des Moines 20
Hanoi 20
Redondo Beach 19
São Paulo 19
Istanbul 18
Munich 18
Bremen 16
Rome 16
Nürnberg 15
Lagos 14
Lucca 14
Brussels 13
Buffalo 13
Marseille 13
Dearborn 12
San Diego 12
Düsseldorf 11
Jacksonville 11
Mumbai 11
Fuzhou 9
Ogden 9
Phoenix 9
Guangzhou 8
Tashkent 8
Toronto 8
Vancouver 8
Columbus 7
Livorno 7
Orem 7
The Dalles 7
Warsaw 7
Amsterdam 6
Chennai 6
Dakar 6
Johannesburg 6
Kent 6
Nuremberg 6
Pistoia 6
Pune 6
Atlanta 5
Belo Horizonte 5
Bexley 5
Bologna 5
Brooklyn 5
Capannori 5
Changsha 5
Jakarta 5
Kunming 5
Manchester 5
Nanchang 5
Poplar 5
Redwood City 5
Salvador 5
Tagliacozzo 5
Turku 5
Alessandria 4
Amman 4
Baghdad 4
Boulder 4
Totale 4.803
Salva come PNG Salva come JPEG
Nome #
1,2-Benzisothiazole Derivatives Bearing 4-, 5-, or 6-Alkyl/arylcarboxamide Moieties Inhibit Carbonic Anhydrase Isoform IX (CAIX) and Cell Proliferation under Hypoxic Conditions 407
From pollen grains to functionalized microcapsules: a facile chemical route using ionic liquids 288
Exploiting the Pyrazolo[3,4-d]pyrimidin-4-one ring system as a useful template to obtain potent adenosine deaminase inhibitors, 272
N-(aroyl)-N-(arylmethyloxy)-α-alanines: selective inhibitors of aldose reductase 251
Acid Derivatives of Pyrazolo[1,5-a]pyrimidine as Aldose Reductase Differential Inhibitors 249
CLM29, a multi-target pyrazolopyrimidine derivative, has anti-neoplastic activity in medullary thyroid cancer in vitro and in vivo 247
Sonde diagnostiche per evidenziare all’infrarosso cellule e tessuti affetti da condizioni patologiche o metaboliche 229
Novel pyrazolopyrimidine derivatives as tyrosine kinase inhibitors with antitumoral activity in vitro and in vivo in papillary dedifferentiated thyroid cancer. 228
Functional Studies in the Year of Pulses: the case of Zolfino landraces (Phaesolus vulgaris L.) 225
Synthesis and investigation of polyhydroxylated pyrrolidine derivatives as novel chemotypes showing dual activity as glucosidase and aldose reductase inhibitors 218
Challenging clinically unresponsive medullary thyroid cancer: Discovery and pharmacological activity of novel RET inhibitors 214
Investigation of new 2-aryl substituted Benzothiopyrano[4,3-d]pyrimidines as kinase inhibitors targeting vascular endothelial growth factor receptor 2 209
Diagnostic probes to detect cells and tissues afflicted with a pathological or metabolic condition by means of infrared spectroscopy 208
Structure-Based Optimization of Tyrosine Kinase Inhibitor CLM3. Design, Synthesis, Functional Evaluation, and Molecular Modeling Studies. 205
pH-responsive carboxymethylcellulose nanoparticles for 68Ga-WBC labeling in PET imaging 203
A Series of COX-2 Inhibitors Endowed with NO-Releasing Properties: Synthesis, Biological Evaluation, and Docking Analysis 202
Combined Use of Scanning Electron Microscopy-Energy-Dispersive X-ray Spectroscopy and Fourier Transform Infrared Imaging Coupled with Principal Component Analysis in the Study of Ancient Egyptian Papyri 194
Dual Kit/Aur Inhibitors as Chemosensitizing Agents for the Treatment of Melanoma: Design, Synthesis, Docking Studies and Functional Investigation 185
Chiral ionic liquids supported on natural sporopollenin microcapsules 181
Effects of the new aldose reductase inhibitor benzofuroxane derivative bf-5m on high glucose induced prolongation of cardiac qt interval and increase of coronary perfusion pressure 180
Geometrically Constrained Derivatives of Indolylglyoxylamides as Ligands Binding the GABAA/BzR Complex. 167
FOXD1-ALDH1A3 signaling is a determinant for the self-renewal and tumorigenicity of mesenchymal glioma stem cells 166
Imidazo[1,2- a]pyridine derivatives as aldehyde dehydrogenase inhibitors: Novel chemotypes to target glioblastoma stem cells 164
Derivati a nucleo benzo[d]isotiazol-3(2H)-one-1,1-diossido e loro impiego nel trattamento di tumori 159
Oxy-imino saccharidic derivatives as a new structural class of aldose reductase inhibitors endowed with anti-oxidant activity 156
Synthesis, biological evaluation and docking analysis of a new series of methylsulfonyl and sulfamoyl acetamides and ethyl acetates as potent COX-2 inhibitors 149
ANTI-ISCHEMIC ACTIVITY OF AN ANTIOXIDANT ALDOSE REDUCTASE INHIBITOR ON DIABETIC AND NON-DIABETIC RAT HEARTS 146
Derivati a nucleo pirazolo[3,4-d]pirimidinico quali inibitori di proteine tirosina chinasi 146
A novel 2,3-diphenyl-4H-pyrido[1,2-a]pyrimidin-4-one derivative inhibits endothelial cell dysfunction and smooth muscle cell proliferation/activation 145
Pyrazolopyrimidine Derivatives as Antineoplastic Agents: with a Special Focus on Thyroid Cancer 136
Copper-Catalyzed Recyclable Synthesis of (Z )-3-Alkylideneisoindolinones by Cycloisomerization of 2-Alkynylbenzamides in Ionic Liquids 133
Cyclodextrin-​based nanosponges for the targeted delivery of the anti-​restenotic agent DB103: A novel opportunity for the local therapy of vessels wall subjected to percutaneous intervention 133
Synthesis and Biological Evaluation of 2'-Oxo-2,3-dihydro-3'H-spiro[chromene-4,5'-[1,3]oxazolidin]3'il]acetic Acid Derivatives as Aldose reductase Inhibitors 130
Synthetic analogues of flavonoids with improved activity against platelet activation and aggregation as novel prototypes of food supplements 125
Agente terapeutico per il trattamento dei vasi sanguigni 117
null 109
null 104
Nanostructured ultra-thin patches for ultrasound-modulated delivery of anti-restenotic drug 104
null 82
Totale 7.166
Salva come PNG Salva come JPEG
Categoria #
all - tutte 18.573
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 18.573
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021116 0 0 0 0 0 0 0 0 0 0 23 93
2021/2022558 24 35 21 33 85 60 29 45 36 9 30 151
2022/2023779 99 136 74 69 97 87 16 42 118 5 32 4
2023/2024374 32 33 57 15 36 81 24 5 7 18 27 39
2024/20251.243 11 45 3 85 147 159 89 63 133 159 114 235
2025/20261.532 133 149 188 164 192 117 237 89 79 173 11 0
Totale 7.166